Defence Therapeutics (DTCFF) Q2 2026 Earnings Report
DTCFF Q2 2026 EPS Results
- Actual EPS
- -$0.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.01
DTCFF Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 02/20/2026
- Time
- After Close
- Conference Call
- Friday, February 20, 2026
DTCFF Upcoming Earnings
Defence Therapeutics's next earnings date is estimated for November 20, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DTCFF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 20, 2026 | 2027 (Q1) | ―- | -0.01 | ― | ― |
| Oct 29, 2026 | 2026 (Q4) | ―- | -0.01 | ― | |
| May 22, 2026 | 2026 (Q3) | ―-0.04 | -0.01 | -163.16% (-0.02) | |
| Feb 20, 2026 | 2026 (Q2) | ―-0.02 | -0.01 | -64.71% (-0.01) | |
| Nov 27, 2025 | 2026 (Q1) | ―- | -0.01 | ― | |
| Oct 28, 2025 | 2025 (Q4) | ―-0.01 | -0.01 | 0.00% (+0.00) | |
| May 23, 2025 | 2025 (Q3) | ―-0.01 | -0.02 | 36.67% (+0.01) | |
| Feb 25, 2025 | 2025 (Q2) | ―-0.01 | -0.14 | 91.01% (+0.12) | |
| Nov 12, 2024 | 2025 (Q1) | ―-0.01 | -0.04 | 74.00% (+0.03) | |
| Sep 20, 2024 | 2024 (Q4) | ―-0.02 | -0.03 | 25.00% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
